Is it safe to add magnesium glycinate to a patient taking mirabegron 25 mg daily and pregabalin 25 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safety of Adding Magnesium Glycinate to Mirabegron and Pregabalin

Yes, it is safe to add magnesium glycinate to your current regimen of mirabegron 25 mg and pregabalin 25 mg daily. There are no known clinically significant drug interactions between magnesium supplements and either mirabegron or pregabalin, and this combination can be used without concern for major adverse effects.

Rationale for Safety

No Direct Drug Interactions

  • Pregabalin has few drug interactions and is not metabolized by the liver—it is eliminated unchanged through the kidneys 1. This pharmacokinetic profile means it does not interact with magnesium through metabolic pathways.

  • Mirabegron is a beta-3 adrenergic agonist with a distinct mechanism of action that does not involve pathways affected by magnesium supplementation 2. The FDA labeling for mirabegron does not list magnesium as a contraindication or interaction 2.

  • Magnesium glycinate is well-tolerated and has been studied in combination with other medications without significant safety concerns 3.

Supporting Evidence for Combination Use

  • A recent high-quality study demonstrated that combining magnesium with other supplements (vitamin D) was safe and well-tolerated in a 12-week randomized controlled trial 3.

  • Another 2024 study showed that preoperative combination of pregabalin with intravenous magnesium sulfate resulted in improved pain control without increased adverse effects, demonstrating safety of concurrent use 4.

Practical Considerations

Dosing and Timing

  • Start with standard magnesium glycinate doses (typically 200-400 mg elemental magnesium daily), as this form has good bioavailability and minimal gastrointestinal side effects.

  • Take magnesium at a different time than pregabalin if possible (e.g., magnesium with dinner, pregabalin at bedtime) to minimize any theoretical absorption interference, though this is not a documented concern.

Monitoring Points

  • Watch for additive sedation: Both pregabalin and magnesium can cause mild drowsiness 1, 5. While pregabalin at your low dose (25 mg) is unlikely to cause significant sedation, be aware of cumulative effects.

  • Monitor for dizziness: Pregabalin commonly causes dose-dependent dizziness 1, 5, and mirabegron can affect blood pressure 2. While magnesium doesn't typically worsen these effects, be cautious when standing quickly.

  • Renal function: Both pregabalin and mirabegron require dose adjustment in renal impairment 1, 2. If you have kidney disease, ensure your doses are appropriate and that magnesium supplementation is approved by your physician, as magnesium is renally excreted.

Common Pitfalls to Avoid

  • Don't assume all magnesium forms are equal: Magnesium glycinate is preferred over magnesium oxide or citrate for better absorption and fewer gastrointestinal side effects.

  • Don't exceed recommended magnesium doses without medical supervision, as excessive magnesium can cause diarrhea and, in rare cases with renal impairment, hypermagnesemia.

  • Don't stop pregabalin abruptly if you experience any issues—this medication should be tapered 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.